ACHF_Donate DONATE NOW

Protecting Students from MenB: A Partnership with Pfizer

Serogroup B meningococcal disease (MenB) is the leading cause of meningococcal disease among U.S. adolescents and young adults and accounts for approximately 60% of all meningococcal disease cases in persons 16 to 23 years of age in the United States. MenB is an uncommon but deadly disease that progresses rapidly and is often difficult to diagnose early enough to treat effectively. Despite appropriate medical treatment ~10% of people with MenB die and one in five survivors experience long-term physical and mental disabilities. College-age persons—adolescents and young adults—are uniquely susceptible to meningococcal disease due to inherent environmental and social risk factors such as close-quartered living and sharing behaviors.

ACHF, in partnership with Pfizer, has developed educational brochures for key stakeholders to bridge the gap of knowledge regarding MenB and MenB vaccines. These materials were developed specifically for college students and campus health professionals/administrators.

For Health Care Professionals

meningitis B

Developed in partnership with Pfizer, this brochure provides education to college health professionals/administrations around serogroup B meningococcal disease (MenB) and preventive vaccination to help provide adequate protection of college-age individuals.

The brochure includes information on the causes, symptoms, and spread of meningococcal disease; epidemiology of meningococcal disease among college students; recommendations from the CDC Advisory Committee on Immunization Practices and who should be vaccinated; and developing a pre-matriculation plan. The brochure can be ordered as a free downloadable PDF through the ACHA Store.  

Download the Brochure



For Students

menB

Developed in partnership with Pfizer, this digital brochure provides education to college students on the causes, symptoms, and spread of serogroup B meningococcal disease (MenB). The brochure also highlights prevention of MenB through vaccination and the rates of MenB compared to other serogroups.

Available materials include a PDF version as well as images to be shared on a campus website or through social media accounts.